Healthcare revenue cycle management company Aspirion appointed Scott Doolittle CFO, effective April 1.
Mr. Doolittle previously served as CFO of Quantum Health, where he led significant financial growth through a combination of strategic mergers and acquisitions and organic growth initiatives.
The appointment comes less than five months after Nick Giannasi took over as Aspirion CEO. Mr. Giannasi succeeded Amy Amick, who moved to the Aspirion’s board in November. She had served as CEO since April 2023.
“In Scott, we’ve found a financial strategist who understands the economic realities facing hospital CFOs and revenue cycle leaders today,” Mr. Giannasi said in an April 1 news release. “His experience scaling healthcare technology companies through private equity partnerships directly mirrors Aspirion’s trajectory.”
